Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on June 30, 2026 by admin

AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images

Conditions: Basal Cell Carcinoma

Sponsors: Istanbul Training and Research Hospital

Recruiting
CategoriesClinicalTrials.gov TagsAcademic research, Healthcare provider

Post navigation

Previous PostPrevious Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
Next PostNext Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) – Frozen Embryo Transfer (FET) Cycles
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.